• Users Online: 59
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2019  |  Volume : 4  |  Issue : 1  |  Page : 4-13

Radiotherapy and devices in cancer patients: What is new in clinical practice?


1 Department of Cardiology, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy
2 Department of Cardiology, Ordine Mauriziano Hospital, Torino, Italy
3 Department of Cardiology, Umberto I-Lancisi-Salesi University Hospital, Ancona, Italy
4 Division of Cardiology, S. Filippo Neri Hospital, Rome, Italy
5 Cardiology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy
6 Department of Cardiothoracic, Maastricht University Hospital, Maastricht, The Netherlands
7 Division of Cardiology, Augusto Murri Hospital, Fermo, Italy
8 Department of Cardiothoracic, University Hospital of Trieste, Trieste, Italy
9 Cardiology Division, Paolo Borsellino Hospital, Marsala, Italy
10 Cardiology Division, Garibaldi-Nesima Hospital, Catania; Heart Care Foundation, Florence, Italy

Correspondence Address:
Dr. Fabiana Luca
Department of Cardiology, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJHR.IJHR_2_19

Rights and Permissions

There has been a significant increase in cancer patients with implanted electronic devices which have been exposed to the risk of malfunction when undergoing radiotherapy in the last few years. In this review, we provide a short summary of radiotherapy principles, later analyzing in vitro and in vivo data and recent recommendations, in order to present the current evidence on predictive factors, risk stratification, and management of patients with implanted electronic devices requiring radiotherapy. The risk of device failure is usually transient, seldom permanent and mainly related to patients' characteristics and cumulative doses administrated during radiotherapy. The strongest predictive factors of implanted electronic device malfunction are higher radiation doses and higher beam energy. Indeed, energy <6 MV and a total dose of 2 Gy are recommended. A close multidisciplinary collaboration involving cardiac electrophysiologists, radiotherapists, and physicists may have important consequences in clinical practice, enabling then to minimize this risk.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed133    
    Printed8    
    Emailed0    
    PDF Downloaded29    
    Comments [Add]    

Recommend this journal